Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia (Q44233121)

1 December 2017

title

Novel E2F decoy oligodeoxynucleotides inhibit in vitro vascular smooth muscle cell proliferation and in vivo neointimal hyperplasia (English)

1 reference

1 December 2017

Ahn JD

1

1 reference

1 December 2017

Morishita R

2

1 reference

1 December 2017

Kaneda Y

3

1 reference

1 December 2017

Kim HS

4

1 reference

1 December 2017

Chang YC

5

1 reference

1 December 2017

Lee KU

6

1 reference

1 December 2017

Park JY

7

1 reference

1 December 2017

Lee HW

8

1 reference

1 December 2017

Kim YH

9

1 reference

1 December 2017

Lee IK

10

1 reference

1 December 2017

publication date

1 December 2002

1 reference

1 December 2017

1 reference

1 December 2017

volume

9

1 reference

1 December 2017

issue

24

1 reference

1 December 2017

page(s)

1682-1692

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301849

1 December 2017

exact match

0 references

cites work

Multiple sequence elements of a single functional class are required for cyclic AMP responsiveness of the mouse c-fos promoter

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Sequence-specific interaction of alpha-beta-anomeric double-stranded DNA with the p50 subunit of NF kappa B: application to the decoy approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Regulation of gene expression with double-stranded phosphorothioate oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Ex vivo regulation of specific gene expression by nanomolar concentration of double-stranded dumbbell oligonucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Sequence-independent inhibition of RNA transcription by DNA dumbbells and other decoys.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Sequence-specific inhibition of a transcription factor by circular dumbbell DNA oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Restenosis after coronary angioplasty. Potential biologic determinants and role of intimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

A Restriction Point for Control of Normal Animal Cell Proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Retinoblastoma protein switches the E2F site from positive to negative element

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Association of cdk2 Kinase with the Transcription Factor E2F During S Phase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Human cyclin-dependent kinase 2 is activated during the S and G2 phases of the cell cycle and associates with cyclin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

The retinoblastoma protein and cell cycle control

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

The stability of different forms of double-stranded decoy DNA in serum and nuclear extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Specific inhibition of influenza virus RNA polymerase and nucleoprotein gene expression by circular dumbbell RNA/DNA chimeric oligonucleotides containing antisense phosphodiester oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Techniques for using antisense oligodeoxyribonucleotides to study gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Transcription factor decoy for activator protein-1 (AP-1) inhibits high glucose- and angiotensin II-induced type 1 plasminogen activator inhibitor (PAI-1) gene expression in cultured human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Angiotensin II signaling in vascular smooth muscle cells under high glucose conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

Specific interaction between enhancer-containing molecules and cellular components

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

7 January 2021

A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

7 January 2021

Restenosis after percutaneous transluminal coronary angioplasty: have we been aiming at the wrong target?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

7 January 2021

Cyclin A is required at two points in the human cell cycle

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

7 January 2021

Mechanisms of action of troglitazone in the prevention of high glucose-induced migration and proliferation of cultured coronary smooth muscle cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301849

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301849

1 reference

1 December 2017

1 reference